Clinical outcomes and prognostic factors of cyberknife stereotactic ...

Cyberknife SBRT appears to be an effective non-invasive treatment for local unresectable HCC with low risk of severe toxicity.

Cyberknife SBRT appears to be an effective non-invasive treatment for local unresectable HCC with low risk of severe toxicity. These results ...

Clinical Outcomes and Prognostic Factors of Salvage Stereotactic ...

The study aimed to assess the efficacy and safety of stereotactic body radiotherapy (SBRT) using CyberKnife (CK) in patients with postoperative thoracic ...

Clinical Outcomes and Prognostic Factors of Salvage Stereotactic ...

The study aimed to assess the efficacy and safety of stereotactic body radiotherapy (SBRT) using CyberKnife (CK) in patients with postoperative thoracic oligo- ...

Peer Review reports - BMC Cancer - BioMed Central

In this study, we report our clinical experience with Cyberknife ... Peer Review reports. From: Clinical outcomes and prognostic factors of cyberknife ...

(PDF) Clinical outcomes and prognostic factors of cyberknife ...

Median survival was 15 months (4-25 months). Overall survival (OS) at 1- and 2-years was 63.5 %(54-71.5 %) and 41.3 % (31.6-50.6 %), ...

Clinical outcomes and prognostic factors of stereotactic body ...

Median overall survival was 15 months (95% CI, 7.22-22.78). 1- and 2-years survival rates were 57.1% and 32.1%, and 1- and 2- years Progression- ...

Clinical outcomes of cyberknife stereotactic radiosurgery for lung ...

The average tumor volume was 14.6 cm3 and the prescribed radiation dosage ranged from 30 to 60 Gy, fractionated one to five times with a 60% to 88% isodose line ...

Clinical Outcomes and Prognostic Factors of Fractionated ...

This study investigated the outcomes and prognostic factors of fractionated stereotactic radiosurgery (FSRS) for treatment of brain metastases (BMs) ≥20 mm ...

Clinical outcomes and prognostic factors of stereotactic body ...

Stereotactic body radiation therapy (SBRT) has been an emerging non-invasive treatment modality for patients with intrahepatic ...

Clinical outcomes of CyberKnife stereotactic radiosurgery for elderly ...

The pooled mean survival for patients without anticancer treatment was 7.15 months (5,6). Even for T1 early stage NSCLC, the median survival ...

Clinical outcomes of CyberKnife stereotactic body radiotherapy for ...

The causes of intercurrent death are summarized in Table 5. The estimated overall survival was 86 % at 1 year and 74 % at 2 years. The 2-year ...

Clinical outcomes of reirradiation of brain metastases from - Lippincott

Nine patients (32.1%) had Graded Prognostic Assessment (GPA) scores 0-1 and 19 patients (67.9%) had GPA scores 1.5-2.5. 19 patients (70%) received whole brain ...

Pancreatic Cancer FAQ - CyberKnife

“Clinical outcomes and prognostic factors of stereotactic body radiation therapy combined with gemcitabine plus capecitabine for locally advanced ...

Factors Affecting Patient-Reported Outcomes Following CyberKnife ...

Factors Affecting Patient-Reported Outcomes Following CyberKnife Stereotactic Body Radiation Therapy for Prostate Cancer · Purpose/Objective(s). Urinary symptoms ...

Clinical outcomes and prognostic factors of stereotactic body ...

The 1-year and 2-year survival rates were 82.1% and 35.7%, whereas the 1-year and 2-year PFS rates were 48.2% and 14.3%, respectively. The median carbohydrate ...

Stereotactic body radiotherapy with CyberKnife® System ... - Frontiers

Biochemical disease-free survival (bDFS) was defined using the Phoenix method (nadir + 2 ng/ml) (29). SBRT-related outcomes were analyzed in the patients with a ...

Talking to Your Doctor About Pancreatic Cancer - CyberKnife

Listed below are key studies to support your discussion of CyberKnife treatment with your doctor. Clinical outcomes and prognostic factors of stereotactic body ...

Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy

Stereotactic body radiotherapy (SBRT) reported excellent outcomes and a good tolerability profile in case of central lung tumors.

Brain Tumors - CyberKnife

Delivering stereotactic radiosurgery (SRS) treatments with unrivaled, sub-millimeter accuracy, the CyberKnife provides excellent clinical outcomes in treating a ...